Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyra A Gelderman

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
International Journal of Cancer|March 18, 2004
Beta-glucan enhanced killing of renal cell carcinoma micrometastases by monoclonal antibody G250 directed complement activationCornelis F M Sier, Kyra A Gelderman, Frans A Prins, et al.
Transplant Immunology|December 25, 2013
The NOX2-mediated ROS producing capacity of recipient cells is associated with reduced T cell infiltrate in an experimental model of chronic renal allograft inflammationMarina D Kraaij, Karin M Koekkoek, Kyra A Gelderman, et al.
Immunology Letters|March 21, 2025
Autoantibodies and therapeutic antibodies against complement factor HSaskia Nugteren, Haiyu Wang, Cees van Kooten, et al.
European Journal of Immunology|January 5, 2002
Enhancement of the complement activating capacity of 17-1A mAb to overcome the effect of membrane-bound complement regulatory proteins on colorectal carcinomaKyra A Gelderman, Peter J K Kuppen, Wouter Bruin, et al.
Cancer Research|June 19, 2004
Tumor-specific inhibition of membrane-bound complement regulatory protein Crry with bispecific monoclonal antibodies prevents tumor outgrowth in a rat colorectal cancer lung metastases modelKyra A Gelderman, Peter J K Kuppen, Noriko Okada, et al.
European Journal of Immunology|January 27, 2011
CD68-expressing cells can prime T cells and initiate autoimmune arthritis in the absence of reactive oxygen speciesAngela Pizzolla, Kyra A Gelderman, Malin Hultqvist, et al.
The Journal of Clinical Investigation|October 3, 2007
Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen speciesKyra A Gelderman, Malin Hultqvist, Angela Pizzolla, et al.
The Journal of Biological Chemistry|July 5, 2020
Correction: C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attackLeendert A Trouw, Anders A Bengtsson, Kyra A Gelderman, et al.
Antioxidants & Redox Signaling|August 7, 2007
Rheumatoid arthritis: the role of reactive oxygen species in disease development and therapeutic strategiesKyra A Gelderman, Malin Hultqvist, Lina M Olsson, et al.
The Journal of Biological Chemistry|August 19, 2007
C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attackLeendert A Trouw, Anders A Bengtsson, Kyra A Gelderman, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|March 18, 2004
Beta-glucan enhanced killing of renal cell carcinoma micrometastases by monoclonal antibody G250 directed complement activationCornelis F M Sier, Kyra A Gelderman, Frans A Prins, et al.
Transplant Immunology|December 25, 2013
The NOX2-mediated ROS producing capacity of recipient cells is associated with reduced T cell infiltrate in an experimental model of chronic renal allograft inflammationMarina D Kraaij, Karin M Koekkoek, Kyra A Gelderman, et al.
Immunology Letters|March 21, 2025
Autoantibodies and therapeutic antibodies against complement factor HSaskia Nugteren, Haiyu Wang, Cees van Kooten, et al.
European Journal of Immunology|January 5, 2002
Enhancement of the complement activating capacity of 17-1A mAb to overcome the effect of membrane-bound complement regulatory proteins on colorectal carcinomaKyra A Gelderman, Peter J K Kuppen, Wouter Bruin, et al.
Cancer Research|June 19, 2004
Tumor-specific inhibition of membrane-bound complement regulatory protein Crry with bispecific monoclonal antibodies prevents tumor outgrowth in a rat colorectal cancer lung metastases modelKyra A Gelderman, Peter J K Kuppen, Noriko Okada, et al.
European Journal of Immunology|January 27, 2011
CD68-expressing cells can prime T cells and initiate autoimmune arthritis in the absence of reactive oxygen speciesAngela Pizzolla, Kyra A Gelderman, Malin Hultqvist, et al.
The Journal of Clinical Investigation|October 3, 2007
Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen speciesKyra A Gelderman, Malin Hultqvist, Angela Pizzolla, et al.
The Journal of Biological Chemistry|July 5, 2020
Correction: C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attackLeendert A Trouw, Anders A Bengtsson, Kyra A Gelderman, et al.
Antioxidants & Redox Signaling|August 7, 2007
Rheumatoid arthritis: the role of reactive oxygen species in disease development and therapeutic strategiesKyra A Gelderman, Malin Hultqvist, Lina M Olsson, et al.
The Journal of Biological Chemistry|August 19, 2007
C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attackLeendert A Trouw, Anders A Bengtsson, Kyra A Gelderman, et al.
Pageof 5